COMP <GO>
ACCL vs BGSF // ENTERPRISE SCALE & MARKET CAP
Acco Group Holdings Limited (Class A) (NASDAQ) VS. BGSF Inc. (NYSE) • 15-METRIC TALLY: ACCL 7
— BGSF 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BGSF
LAST: $2.59 (-0.38%) • MKT CAP: $36.1M
market-cap
$36.1M
LAST: $4.29 (+0.94%) • MKT CAP: $45.8M
market-cap
$45.8M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACCL VS. BGSF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACCL | BGSF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.10% | 35.70% | +8.40 | ACCL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -24.20% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 32.9x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.19% | 0.31% | +3.88 | ACCL | /fcf-yield <GO> |
| Operating Margin | 22.30% | -9.50% | +31.80 | ACCL | /operating-margins <GO> |
| Net Profit Margin | 21.10% | -12.20% | +33.30 | ACCL | /net-margins <GO> |
| Revenue Growth (YoY) | 12.50% | -10.60% | +23.10 | ACCL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.00 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | ACCL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.3 | 37.7 | +5.59 | ACCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $36.1M | $45.8M | -$9.7M | BGSF | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACCL REV | BGSF REV | ACCL GROSS % | BGSF GROSS % | ACCL FCF | BGSF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.9M | $93.3M | 44.1% | 35.7% | $1.5M | $142.0K |
| FY 2024 | $4.3M | $104.4M | 49.1% | 36.8% | $1.1M | $24.4M |
| FY 2023 | $3.7M | $125.1M | — | — | $742.0K | $20.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACCL // BETA —
BGSF // BETA —